Jane Street’s Maravai LifeSciences MRVI Stock Holding History

Jane Street’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$133K	Sell	21,300 -5,700	-21%	-$24.6K	﹤0.01%	10435
2026 Q1	$76.4K	Buy	27,000 +16,300	+152%	+$55.3K	﹤0.01%	10771
2025 Q4	$34.8K	Buy	+10,700	New	+$36K	﹤0.01%	10610
2024 Q2	–	Sell	-13,300	Closed	-$115K	–	9901
2024 Q1	$115K	Buy	+13,300	New	+$90K	﹤0.01%	8476
2023 Q3	–	Sell	-87,100	Closed	-$1.08M	–	9109
2023 Q2	$1.08M	Buy	+87,100	New	+$1.18M	﹤0.01%	5078
2023 Q1	–	Sell	-28,500	Closed	-$408K	–	9590
2022 Q4	$408K	Sell	28,500 -2,200	-7%	-$34.6K	﹤0.01%	6498
2022 Q3	$784K	Buy	+30,700	New	+$770K	﹤0.01%	5870
2022 Q2	–	Sell	-12,600	Closed	-$444K	–	10434
2022 Q1	$444K	Sell	12,600 -9,400	-43%	-$315K	﹤0.01%	7705
2021 Q4	$922K	Sell	22,000 -147,500	-87%	-$5.97M	﹤0.01%	6058
2021 Q3	$8.32M	Buy	169,500 +163,000	+2,508%	+$7.95M	﹤0.01%	2041
2021 Q2	$271K	Hold	6,500	–	–	﹤0.01%	8331
2021 Q1	$232K	Buy	+6,500	New	+$215K	﹤0.01%	8068

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

1WCM

12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OAM

Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Jane Street's MRVI Position: Q2 2026 in Review

Jane Street reduced its Maravai LifeSciences (MRVI) stake by 91% in Q2 2026, selling an estimated $6.45M and leaving 142,590 shares worth $890K. The position accounts for ﹤0.01% of the portfolio, ranked #6779.

Jane Street first reported a position in MRVI in Q4 2020 and has held it in 21 quarters since. The position peaked at $4.63M in Q1 2026. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

Jane Street held 142,590 shares of Maravai LifeSciences worth $890K as of Q2 2026.
Jane Street sold 1,493,555 Maravai LifeSciences shares in Q2 2026, an estimated $6.45M.
Maravai LifeSciences made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #6779 holding.
Jane Street first reported a position in Maravai LifeSciences in Q4 2020 and has held it in 21 quarters since.
Jane Street's Maravai LifeSciences position peaked at $4.63M in Q1 2026.
178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.